SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on May 13, 2019. The filing serves to announce the company's financial results for the three months ended March 31, 2019. The registrant is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol RMED. The company is identified as an emerging growth company.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained in a press release attached as Exhibit 99.1, which is incorporated by reference but not included in the text of this summary.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not include specific guidance, outlook, management commentary, or risk factors. It notes that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other documents unless expressly stated.
Key Facts for Investor Verification
- Company Name Discrepancy: The request metadata lists "Catheter Precision, Inc.," but the filing is for Ra Medical Systems, Inc. Verify the correct entity.
- Missing Data: No financial figures (revenue, net income, cash) are present in the 8-K text; they are located in the attached Exhibit 99.1 press release.
- Reporting Period: Results cover the quarter ended March 31, 2019.
- Legal Status: The financial information in this specific 8-K is furnished, not filed, limiting its incorporation into future registration statements.